Performance Assessment Tests in Working Individuals With DME Following Treatment With Ranibizumab

Summary

Performance assessment testing may be a useful tool to evaluate the impact of ranibizumab on day-to-day visual function in patients with Diabetic Macular Edema (DME).

Timeline

Start

2015-03-13

Primary completion

2017-05-15

Completion

2017-05-15

Drugs

Indications